dalteparin has been researched along with Abscess, Amebic, Hepatic in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amebic liver abscess is the most common extraintestinal manifestation." | 1.35 | Budd-Chiari syndrome as a vascular complication of amebic liver abscess. ( Aoun, O; Barruet, R; Ficko, C; Imbert, P; Méchaï, F; Rapp, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Méchaï, F | 1 |
| Aoun, O | 1 |
| Ficko, C | 1 |
| Barruet, R | 1 |
| Imbert, P | 1 |
| Rapp, C | 1 |
1 other study available for dalteparin and Abscess, Amebic, Hepatic
| Article | Year |
|---|---|
Budd-Chiari syndrome as a vascular complication of amebic liver abscess.
Topics: Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Budd-Chiari Syndrome; Enoxaparin; Humans; | 2009 |